Xingbo Xu
- Nephrology top 5%
- Parathyroid Disorders and Treatments 3
- Cancer Research top 10%
-
- Cardiac Valve Diseases and Treatments 4
- Cardiovascular Function and Risk Factors 3
- Molecular Biology top 10%
- Renal and related cancers 7
- CRISPR and Genetic Engineering 6
- Pluripotent Stem Cells Research 6
- Congenital heart defects research 5
- Epigenetics and DNA Methylation 4
- Co-authors
- Elisabeth M. ZeisbergMichael ZeisbergXiao-Ying TanBjörn TampeRaghu KalluriMelanie S. HulshoffElisa SánchezD. V. Krishna Pantakani
- Partner nations
- GermanyChinaUnited States
In The Last Decade
Xingbo Xu
43 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 89
- Nephrology 168
- Cancer Research 200
- Cardiology and Cardiovascular Medicine 293
- Molecular Biology 810
- Pulmonary and Respiratory Medicine 203
Countries citing papers authored by Xingbo Xu
This map shows the geographic impact of Xingbo Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingbo Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingbo Xu more than expected).
Fields of papers citing papers by Xingbo Xu
This network shows the impact of papers produced by Xingbo Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingbo Xu. The network helps show where Xingbo Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xingbo Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 12 | |
| 5 | 2023 | 28 | |
| 6 | 2022 | 5 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 13 | |
| 9 | 2020 | 2 | |
| 10 | 2018 | 107 | |
| 11 | 2018 | 13 | |
| 12 | 2016 | 26 | |
| 13 | 2016 | 27 | |
| 14 | 2016 | 18 | |
| 15 | 2015 | 141 | |
| 16 | 2014 | 11 | |
| 17 | 2014 | 84 | |
| 18 | 2014 | 112 | |
| 19 | 2013 | 39 | |
| 20 | Phenotypic Characterization of the LOXL1 Null Mouse | 2009 | 2 |
About Xingbo Xu
Xingbo Xu is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Business and International Management, having authored 46 papers that have together received 1.4k indexed citations. Recurring topics across this work include Renal and related cancers (7 papers), CRISPR and Genetic Engineering (6 papers), Pluripotent Stem Cells Research (6 papers), Congenital heart defects research (5 papers), Cardiac Valve Diseases and Treatments (4 papers), Epigenetics and DNA Methylation (4 papers), Parathyroid Disorders and Treatments (3 papers) and Cardiovascular Function and Risk Factors (3 papers). The work is most often cited by research in Nephrology (168 citations), Cancer Research (200 citations) and Cardiology and Cardiovascular Medicine (293 citations). Xingbo Xu has collaborated with scholars based in Germany, China and United States. Frequent co-authors include Elisabeth M. Zeisberg, Michael Zeisberg, Xiao-Ying Tan, Björn Tampe, Raghu Kalluri, Melanie S. Hulshoff, Elisa Sánchez, D. V. Krishna Pantakani, Wolfgang Engel and Guido Krenning.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.